PRTA : Summary for Prothena Corporation plc - Ordi - Yahoo Finance

U.S. Markets close in 5 hrs 44 mins

Prothena Corporation plc (PRTA)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
55.41+1.53 (+2.84%)
As of 10:15 AM EST. Market open.
People also watch:
PTLAOPHTAGIOPTCTALDR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close53.88
Open55.01
Bid54.92 x 100
Ask55.15 x 100
Day's Range53.48 - 55.83
52 Week Range28.20 - 73.47
Volume94,096
Avg. Volume390,265
Market Cap1.91B
Beta3.18
PE Ratio (TTM)-13.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is Prothena Corporation PLC (PRTA) Going to Burn These Hedge Funds?
    Insider Monkey8 hours ago

    Is Prothena Corporation PLC (PRTA) Going to Burn These Hedge Funds?

    At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]

  • Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : December 2, 2016
    Capital Cube3 days ago

    Prothena Corp. Plc breached its 50 day moving average in a Bearish Manner : PRTA-US : December 2, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Prothena Corp. Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop
    Investor's Business Daily5 days ago

    Celgene, Kite, Spark Look To Sidestep Lilly Alzheimer's Flop

    Celgene, Gilead and Spark are looking to sidestep Eli Lilly's Alzheimer's flop during the American Society of Hematology conference.